1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, February 2019 (p10)

Biotechnology Analysis & Statistics in the United States, February 2019 (p10)

Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

271-300 of about 3200 reports

Global Biologics Market Research Report: by Product, by Disease Indication, by Manufacturing, and Region - Forecast to 2023

Global Biologics Market Research Report: by Product, by Disease Indication, by Manufacturing, and Region - Forecast to 2023

  • $ 4450
  • Industry report
  • February 2019

Global Biologics Market Research Report: by Product (Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, Gene Therapy, Others), by Disease Indication (Rheumatoid Arthritis, Psoriasis/Psoriatic ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Global Next Generation Sequencing Market Analysis & Trends - Industry Forecast to 2027

Global Next Generation Sequencing Market Analysis & Trends - Industry Forecast to 2027

  • $ 4200
  • Industry report
  • February 2019

The Global Next Generation Sequencing Market is poised to grow strong during the forecast period 2017 to 2027.Some of the prominent trends that the market is witnessing include increasing adoption in clinical ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology, Diagnostics, Medical Biotechnology
  • Countries : World, United States
Global Molecular Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

Global Molecular Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • Industry report
  • February 2019

Market OverviewThe global molecular diagnostics market was valued at USD 7,854.45 million in 2018, and is estimated to be valued at USD 13,340.35 million by 2024, while witnessing a CAGR of 9.23% during ...

  • Industries : Diagnostics, Medical Biotechnology, Healthcare, Biotechnology
  • Countries : World, United States, North America
Degenerative Disc Disease - Pipeline Review, H1 2019

Degenerative Disc Disease - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

Degenerative Disc Disease - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Pipeline Review, H1 2019, provides ...

  • Industries : Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical, Pathology
  • Countries : United States
Dilated Cardiomyopathy - Pipeline Review, H1 2019

Dilated Cardiomyopathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

Dilated Cardiomyopathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2019, provides ...

  • Industries : Chronic Disease, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States
Hidradenitis Suppurativa - Pipeline Review, H1 2019

Hidradenitis Suppurativa - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

Hidradenitis Suppurativa - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hidradenitis Suppurativa - Pipeline Review, H1 2019, provides ...

  • Industries : Pathology, Healthcare, Therapy, Medical Biotechnology
  • Countries : United States
House Dust Mite Allergy - Pipeline Review, H1 2019

House Dust Mite Allergy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

House Dust Mite Allergy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H1 2019, provides ...

  • Industries : Chronic Disease, Medical Biotechnology, Pathology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States
Phenylketonuria (PKU) - Pipeline Review, H1 2019

Phenylketonuria (PKU) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

Phenylketonuria (PKU) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria (PKU) - Pipeline Review, H1 2019, provides an ...

  • Industries : Pathology, Pharmaceutical, Therapy, Healthcare, Medical Biotechnology
  • Countries : United States
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • January 2019

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis (MPA) - Pipeline Review, H1 ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : World, United States, Japan
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

  • $ 3999
  • Industry report
  • January 2019

INTRODUCTIONGiven their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms across a myriad of clinical conditions, including ...

  • Industries : Pharmaceutical, Therapy, Medical Biotechnology, Drug Delivery
  • Countries : United States
Gazyva

Gazyva

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewGazyva (obinutuzumab; Roche/Biogen/Chugai/Nippon Shinyaku) is a third-generation, type II glycoengineered, humanized anti-CD20 monoclonal antibody (MAb) that recognizes the type II epitope ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, European Union, Japan
Arzerra

Arzerra

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewArzerra (ofatumumab; Genmab/Novartis) is a fully human immunoglobulin G1 and high-affinity antibody that targets a novel epitope on cluster of differentiation 20 (CD20) on the B-cell membrane. ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, Japan, European Union
Yescarta

Yescarta

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewYescarta (axicabtagene ciloleucel; Gilead) became the first chimeric antigen receptor T-cell (CAR-T) therapy to launch for the treatment of diffuse large B-cell lymphoma (DLBCL) when it gained ...

  • Industries : Medical Biotechnology, Cancer, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Zevalin

Zevalin

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewZevalin (ibritumomab tiuxetan; Acrotech Biopharma/Mundipharma) is an intravenous radioactive agent consisting of the murine monoclonal antibody (MAb) ibritumomab, which is covalently linked ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, Japan
lisocabtagene maraleucel

lisocabtagene maraleucel

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewLisocabtagene maraleucel (also known as JCAR017; Celgene) will be the third autologous chimeric antigen receptor T-cell (CAR-T) therapy to reach the diffuse large B-cell lymphoma (DLBCL) market ...

  • Industries : Cancer, Medical Biotechnology, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Cell Therapy in the US - Industry Market Research Report

Cell Therapy in the US - Industry Market Research Report

  • $ 1090
  • Industry report
  • January 2019

Generating growth: Operators will benefit from continued R&D efforts despite profit lossesAbstractCell TherapyThe practices of the Cell Therapy industry fall under the branch of regenerative medicine, ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
United States Cancer Biomarkers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024

United States Cancer Biomarkers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024

  • $ 950
  • Industry report
  • January 2019

The country research report on the United States cancer biomarkers market is a customer intelligence and competitive study of the United States market.Moreover, the report provides deep insights into demand ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : United States
Global Molecular Diagnostics Market – Technologies, Products, Applications and End-Use Sectors

Global Molecular Diagnostics Market – Technologies, Products, Applications and End-Use Sectors

  • $ 4860
  • Industry report
  • January 2019

Report SynopsisEmergence of novel next generation sequencing technologies, extensive use of next generation sequencing technologies in clinical diagnostics, application of sequencing technologies in cance ...

  • Industries : Diagnostics, Medical Biotechnology, Biotechnology
  • Countries : World, APAC, United States, North America, Europe
United States Microbiome Sequencing Services Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024

United States Microbiome Sequencing Services Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024

  • $ 950
  • Industry report
  • January 2019

The country research report on the United States microbiome sequencing services market is a customer intelligence and competitive study of the United States market.Moreover, the report provides deep insights ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : United States
Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology, By End Use And Segment Forecasts, 2019 - 2025

Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology, By End Use And Segment Forecasts, 2019 - 2025

  • $ 4950
  • Industry report
  • January 2019

Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology (Functional Genomics, Epigenomics), By End Use (Pharma & Biotech Companies), And Segment Forecasts, 2019 ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology
  • Countries : United States
Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • Industry report
  • January 2019

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027SummaryThe Rheumatoid Arthritis (RA) market is expected to grow from $23.3bn in 2017 to $27.8bn in 2027 across the eight major markets ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Therapy
  • Countries : Australia, United States, Japan, Australasia, World, Oceania, East Asia, North America
Global Cartilage Repair Market (2018 - 2024)

Global Cartilage Repair Market (2018 - 2024)

  • $ 3600
  • Industry report
  • January 2019

The Global Cartilage Repair Market size is expected to reach $6.4 billion by 2024, rising at a market growth of 8.5% CAGR during the forecast period.Growing epidemiology of such diseases need effective ...

  • Industries : Medical Biotechnology
  • Countries : United States, North America, World
North America Cartilage Repair Market (2018 - 2024)

North America Cartilage Repair Market (2018 - 2024)

  • $ 1500
  • Industry report
  • January 2019

The North America Cartilage Repair Market would witness market growth of 7.7% CAGR during the forecast period (2018 – 2024).The market growth of cartilage repair market is primarily attributed to the ...

  • Industries : Medical Biotechnology
  • Countries : North America, United States
Customized Peptide Synthesis Market (2014-2024)

Customized Peptide Synthesis Market (2014-2024)

  • $ 5100
  • Industry report
  • January 2019

Customized Peptide Synthesis Market (2014-2024)The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent study.. The market is being progressively ...

  • Industries : Biotechnology
  • Countries : APAC, North America, Europe, East Asia, China, United States, Canada, Germany, France, United Kingdom, Italy, Spain, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia, World
Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market (2018-2023)

Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market (2018-2023)

  • $ 2950
  • Industry report
  • January 2019

The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations. According to the NASH Education ...

  • Industries : Diagnostic Imaging
  • Countries : United States, North America, World
Global Multiplex Biomarker Imaging Market (2018–2023)

Global Multiplex Biomarker Imaging Market (2018–2023)

  • $ 2950
  • Industry report
  • January 2019

The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According ...

  • Industries : Medical Biotechnology
  • Countries : United States
Flow Cytometry Market by Technology, Product, End user, Application And Region - Global Forecast to 2023

Flow Cytometry Market by Technology, Product, End user, Application And Region - Global Forecast to 2023

  • $ 5650
  • Industry report
  • January 2019

The global flow cytometry market is projected to grow at a CAGR of 8.1%.The global flow cytometry market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, growing at a CAGR of ...

  • Industries : Medical Biotechnology
  • Countries : United States, North America
Antisense & RNAi Therapeutics Market Analysis Report By Application, By Technology, By Route of Administration And Segment Forecasts, 2019 - 2025

Antisense & RNAi Therapeutics Market Analysis Report By Application, By Technology, By Route of Administration And Segment Forecasts, 2019 - 2025

  • $ 4950
  • Industry report
  • January 2019

Antisense & RNAi Therapeutics Market Analysis Report By Application (Oncology, Cardiovascular, Infectious Diseases), By Technology (siRNA, miRNA), By Route of Administration, And Segment Forecasts, 2019 ...

  • Industries : Therapy
  • Countries : United States
Viral Vector & Plasmid DNA Manufacturing Market Analysis Report By Application, By Disease, By Workflow, By Vector, By End Use And Segment Forecasts, 2019 - 2025

Viral Vector & Plasmid DNA Manufacturing Market Analysis Report By Application, By Disease, By Workflow, By Vector, By End Use And Segment Forecasts, 2019 - 2025

  • $ 4950
  • Industry report
  • January 2019

Viral Vector & Plasmid DNA Manufacturing Market Analysis Report By Application, By Disease (Cancer, Genetic), By Workflow (Upstream, Downstream), By Vector, By End Use, And Segment Forecasts, 2019 - 2025The ...

  • Industries : Medical Biotechnology
  • Countries : United States
MT-2271

MT-2271

  • $ 10000
  • Industry report
  • January 2019

Drug OverviewMT-2271 is a plant-based, recombinant virus-like particle (VLP) QIV seasonal influenza vaccine in development by Mitsubishi Tanabe Pharma. It contains a mix of recombinant hemagglutinin proteins ...

  • Industries : Therapy
  • Countries : United States, European Union

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on